DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Five Prime Therapeutics, Inc. (FPRX)
« Back to company indexFPRX Chatter Timeline
Stock Ticker for FPRX
Most Active Tweeters for FPRX
| User | Tweets |
|---|---|
| @bulletin_en | 8 |
| @AmericanBanking | 4 |
| @StockMatusow | 2 |
| @ZolmaxNews | 2 |
| @bbnsnews | 2 |
Recent Tweets for FPRX
 |
@OlympiaReport Five Prime Therapeutics Inc $FPRX Given Consensus Recommendation of “Hold” by Brokerages https://t.co/PInInzgxnO May 23rd 2019, 6:05pm |
 |
@AmericanBanking Five Prime Therapeutics Inc $FPRX Receives Consensus Recommendation of “Hold” from Analysts https://t.co/W8pOYiRiVt #stocks May 23rd 2019, 6:05pm |
 |
@bulletin_en Selecta Biosciences Inc. $FPRX Comparing side by side https://t.co/CYR9elO86Q May 23rd 2019, 6:05pm |
 |
@bbnsnews $5.01 Million in Sales Expected for Five Prime Therapeutics Inc $FPRX This Quarter https://t.co/nw9OneTGsG May 21st 2019, 12:05am |
|
@bulletin_en Contrasting of Aimmune Therapeutics Inc. $FPRX https://t.co/A8lII56aHm May 18th 2019, 2:05pm |
 |
@WatchlistN Analysts Anticipate Five Prime Therapeutics Inc $FPRX Will Announce Earnings of -$0.89 Per Share https://t.co/65F1svVwF8 May 18th 2019, 11:05am |
 |
@macondailynews BidaskClub Lowers Five Prime Therapeutics $FPRX to Sell https://t.co/rjjBjk7WPC May 18th 2019, 10:05am |
 |
@dakotafinancial BidaskClub Lowers Five Prime Therapeutics $FPRX to Sell https://t.co/SV126XmLH4 May 18th 2019, 10:05am |
 |
@TranscriptDaily Five Prime Therapeutics $FPRX Downgraded by BidaskClub https://t.co/NgC9DlC16r May 17th 2019, 11:05am |
 |
@ZolmaxNews Five Prime Therapeutics $FPRX Downgraded by ValuEngine to “Sell” https://t.co/RGVxFlY6jZ May 17th 2019, 11:05am |
 |
@WKRBNews Five Prime Therapeutics $FPRX Downgraded by ValuEngine to “Sell” https://t.co/qBnzmrWFsd #markets May 17th 2019, 11:05am |
 |
@Board_Diversity RT @talent4boards: Five Prime Thx welcomes Carol Schafer to #BoardOfDirectors @FivePrime_FPRX #WomenOnBoard $FPRX https://t.co/T6SmtAOpKj May 17th 2019, 7:05am |
 |
@talent4boards Five Prime Thx welcomes Carol Schafer to #BoardOfDirectors @FivePrime_FPRX #WomenOnBoard $FPRX https://t.co/RoKTnQED1M May 17th 2019, 7:05am |
|
@AmericanBanking Five Prime Therapeutics Inc $FPRX Expected to Post Quarterly Sales of $5.01 Million https://t.co/6h4zIriM2w #stocks May 17th 2019, 3:05am |
 |
@InsiderAlertsIA $FPRX: New Insider Filing on EVP, Chief Scientific Officer BRYAN IRVING: https://t.co/UUhwJGBgsv May 16th 2019, 6:05pm |
 |
@StockTexts $FPRX Five Prime Therapeutics, Inc. SEC Filing: Form 4 https://t.co/pBCuQGRA2V May 16th 2019, 6:05pm |
|
@StockTexts $FPRX Five Prime Therapeutics, Inc. SEC Filing: Form 4 https://t.co/EymLTwO99N May 16th 2019, 6:05pm |
 |
@fintel_io $FPRX / Five Prime Therapeutics files form 8-K https://t.co/D23B03REJr May 16th 2019, 4:05pm |
 |
@1stOncology #FivePrimeTherapeutics Announces #FPA150 Poster Presentation at #ASCO19 $FPRX https://t.co/1i6gF55e2G May 16th 2019, 10:05am |
|
@bulletin_en Madrigal Pharmaceuticals Inc. $FPRX Comparing side by side https://t.co/rYRGPrdgFt May 16th 2019, 12:05am |
 |
@HottestStockNow $FPRX Makes Strategic Move https://t.co/Jshsxlvyt1 May 15th 2019, 9:05pm |
 |
@ProTradersNews $FPRX: Five Prime Therapeutics Appoints Carol Schafer to its Board of …: https://t.co/BdcvY5VSJs May 15th 2019, 6:05pm |
 |
@StockNewsWires $FPRX: Five Prime Therapeutics Announces FPA150 Poster Presentation at …: https://t.co/nDMPNNiMaa May 15th 2019, 5:05pm |
|
@AmericanBanking Five Prime Therapeutics Inc $FPRX Expected to Post Earnings of -$0.89 Per Share https://t.co/ZGVa6OmQqH #stocks May 15th 2019, 10:05am |
|
@bulletin_en Reviewing Quanterix Corporation $FPRX's results https://t.co/J6JV6EJHMH May 14th 2019, 5:05pm |
|
@bulletin_en Rafael Holdings Inc. $FPRX https://t.co/hsZAuwQXD5 May 13th 2019, 6:05pm |
 |
@StockMatusow Disclosure - We have no position in $FPRX currently, long or short. May 13th 2019, 4:05pm |
|
@StockMatusow Want a #biotech that's cash good with a legit shot to run again? See $FPRX - CD 80 - Legit gamble play but prob a b… https://t.co/XF44f5dQH9 May 13th 2019, 4:05pm |
|
@bulletin_en Contrasting of Vericel Corporation $FPRX https://t.co/35f4KQPRKD May 11th 2019, 11:05am |
|
@bbnsnews Five Prime Therapeutics $FPRX Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS https://t.co/vP9OR7gZuW May 11th 2019, 12:05am |
|
@bulletin_en Reviewing Fennec Pharmaceuticals Inc. $FPRX's results https://t.co/rWXkAAJDXO May 10th 2019, 6:05pm |
|
@bulletin_en Reviewing Cyclacel Pharmaceuticals Inc. $FPRX's results https://t.co/6YuvbxtDwR May 10th 2019, 5:05pm |
 |
@BoardSecurities $FPRX don’t mean to butt in as a result insane revenue growth few years back, went on some watch lists but astoun... https://t.co/d7jEZjqmS9 May 10th 2019, 2:05pm |
 |
@ResearchPool $FPRX #Five Prime Therapeutics Inc Q1 Financials; FIGHT Enrollment Update: Increased Risk, Potentially Larger Opp.:… https://t.co/jKhgmcWpjI May 10th 2019, 7:05am |
|
@AmericanBanking Five Prime Therapeutics $FPRX Announces Earnings Results https://t.co/gSZe7TzeQr #stocks May 10th 2019, 12:05am |
|
@ZolmaxNews Five Prime Therapeutics $FPRX Announces Quarterly Earnings Results, Beats Expectations By $0.05 EPS https://t.co/hje347ERR3 May 10th 2019, 12:05am |
 |
@newswelldone $FPRX: Five Prime Therapeutics, Inc. (FPRX) CEO Aron Knickerbocker on …: https://t.co/v9qI8h43pd May 9th 2019, 11:05pm |
 |
@SiteFocusHQ $FPRX Qualitative Analysis of recent earnings identified Five Prime Therapeutics, Inc (NASDAQ: FPRX ) business focu… https://t.co/QGKnrVyGb1 May 9th 2019, 11:05pm |
 |
@SeekingAlpha $FPRX - Five Prime Therapeutics, Inc. (FPRX) CEO Aron Knickerbocker on Q1 2019 Results - Earnings Call Transcript https://t.co/pznxb4QrcA May 9th 2019, 11:05pm |
 |
@EarningsAlley Summary for the Five Prime Therapeutics, Inc. earnings call. $FPRX #earnings #FivePrimeTherapeuticsInc https://t.co/R0aa27ncrl May 9th 2019, 11:05am |
 |
@NewsToDesk $FPRX: Five Prime Therapeutics (FPRX) Q1 2019 Earnings Call Transcript: https://t.co/7yWrVK0DU3 May 9th 2019, 11:05am |
 |
@intercooleronli Head-To-Head Survey: Five Prime Therapeutics $FPRX vs. Celgene $CELG https://t.co/B6IGKQ5zL0 #investingnews May 8th 2019, 8:05pm |
 |
@ledgerzette Head-To-Head Survey: Five Prime Therapeutics $FPRX vs. Celgene $CELG https://t.co/S5DuIcqgwZ #stocks May 8th 2019, 8:05pm |
 |
@Estimize $FPRX beats the Estimize EPS Consensus by 2c and the Estimize Revenue Consensus by $0.45M. Reports FQ1 earnings of… https://t.co/KBii46oW8I May 8th 2019, 4:05pm |
 |
@MarketCurrents $FPRX - Five Prime Therapeutics beats by $0.05, misses on revenue https://t.co/MYKgc7m4Nq May 8th 2019, 4:05pm |
|
@StockTexts $FPRX Five Prime Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/rxOdEafx8f May 8th 2019, 4:05pm |
|
@Estimize $FPRX reports after the close, Estimize Consensus +0.03 EPS and -0.63M Revs compared to WS - https://t.co/jpClYim5Hi May 8th 2019, 11:05am |
 |
@FinZTribune $-1.07 EPS Expected for Five Prime Therapeutics, Inc. $FPRX; Capital International Investors Has Increased Its Matt… https://t.co/Q9j8lERYQV May 7th 2019, 3:05pm |
 |
@surveyist RT @semodough: $FPRX – ASCO Abstract: Ph1 safety/PK data for FPA150 (anti-B7-H4) in advanced solid tumors on 5/15/19 $NCNA – ASCO Abs… May 7th 2019, 7:05am |
 |
@semodough $FPRX – ASCO Abstract: Ph1 safety/PK data for FPA150 (anti-B7-H4) in advanced solid tumors on 5/15/19 $NCNA –… https://t.co/BzgEWedzMp May 7th 2019, 6:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.